Maggie Tabberer

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

David A. Lipson, Frank Barnhart, Noushin Brealey et al. · New England Journal of Medicine · 2018 · 1.2K citations · Full text

FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease

David A. Lipson, Helen Barnacle, Ruby Birk et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 323 citations

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial

Laurie A. Lee, Zelie Bailes, Neil Barnes et al. · The Lancet Respiratory Medicine · 2020 · 239 citations · Full text

Asthma, Pulmonary Care, Allergy +5

Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials

Marc Decramer, Antonio Anzueto, Edward Kerwin et al. · The Lancet Respiratory Medicine · 2014 · 231 citations

Asthma, Umeclidinium Monotherapies, Advanced Lung Disease +6

Tests of the Responsiveness of the COPD Assessment Test Following Acute Exacerbation and Pulmonary Rehabilitation

Paul Jones, Gale Harding, Ingela Wiklund et al. · CHEST Journal · 2012 · 159 citations

Pulmonary Care, Advanced Lung Disease, Acute Exacerbation +7